alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>

EXHIBIT 10.1


                        AMENDMENT TO EMPLOYMENT AGREEMENT
                  BETWEEN PREVIO, INC. AND CLIFFORD L. FLOWERS

         This Amendment ("Amendment") to the Employment Agreement dated January
1, 2001 ("Agreement") is entered into by and between Previo, Inc. ("Previo") and
Clifford L. Flowers ("Executive"). This Amendment incorporates the terms and
conditions of the Agreement and is effective April 24, 2002. Any terms used
below which are defined in the Agreement shall have their respective meanings
set forth in the Agreement.

         NOW, THEREFORE, in consideration of the mutual covenants contained
herein and for other good and valuable consideration, receipt of which is hereby
acknowledged, the parties agree as follows:

To amend section 4.4.3 of the Agreement thereby increasing the benefits
Executive will receive upon termination to (1) one year's base salary (base
salary as determined as the Executive's highest base salary under the
Agreement), and (1) one year's health benefit premiums.

All other terms and conditions of the Agreement remain unchanged.

AGREED TO:

PREVIO, INC.
                                                  EXECUTIVE

By:  /s/Tom Dilatush                              By:     /s/Clifford L. Flowers

Name:  Tom Dilatush                               Name:   Clifford L. Flowers

Title:   Chief Executive Officer

Date:  June 12, 2002                              Date:  June 12, 2002
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Inherited Disease Research Access Committee.                    

*Date:*                         September 11, 2009.                    

*Time:*                         11:30 a.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 5635 Fishers Lane, Suite 4076, Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Camilla E. Day, PhD, Scientific Review Officer, CIDR, National Human Genome Research Institute, National Institutes of Health, 5635 Fishers Lane, Suite 4075, Bethesda, MD 20892, 301-402-8837,                         *camilla.day@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human Genome Research, National Institutes of Health, HHS)

      ( print page 36496)    
Dated: July 16, 2009.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. E9-17437 Filed 7-22-09; 8:45 am]

BILLING CODE 4140-01-P
**Exhibit32.1**

 

**Certificationof Chairman and Chief Executive OfficerPursuant to Section 906 of the Sarbanes-Oxley Act of 2002**

 

The undersigned officer of Watson Pharmaceuticals, Inc. (the“Company”), hereby certifies, to such officer’s knowledge, that:

 

(i)                                     theaccompanying Quarterly Report on Form 10-Q of the Company for the quarter endedSeptember 30, 2003 (the “Report”) fully complies with the requirements ofSection 13(a) or Section 15(d), as applicable, of the Securities Exchange Actof 1934, as amended; and

 

(ii)                                  theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 

 
| Dated:  November 5, 2003 |   |                                 |
|-------------------------------|--------|--------------------------------------|
|                          | By:    | **/s/ Allen Chao, Ph.D.**            |
|                          |   |                                 |
|                          |   | Allen Chao, Ph.D.                    |
|                          |   | Chairman and Chief Executive Officer |
|                          |   | (Principal Executive Officer)        |

 

The foregoingcertification is being furnished solely to accompany the Report pursuant to 18U.S.C. § 1350, and is not being filed for purposes of Section 18 of theSecurities Exchange Act of 1934, as amended, and is not to be incorporated byreference into any filing of the Company, whether made before or after the datehereof, regardless of any general incorporation language in such filing.

 

----
**Exhibit
      10.1**




**Consent
      of Independent Registered Public Accounting Firm**




We
      consent to the incorporation by reference in the Registration Statements on
      Form
      S-8 (Registration No. 333-12586, 333-13786, 333-14142, 333-83914, 333-104070,
      333-121229, 333-138717 and 333-148316) of Alvarion Ltd. of our reports dated
      April 2, 2008, with respect to the consolidated financial statements of Alvarion
      Ltd. and
      the
      effectiveness of internal control over financial reporting of Alvarion Ltd. included
      in this annual report on Form 20-F for the year ended December 31,
      2007.








/s/
                KOST, FORER GABBAY&
                KASIERERTel-Aviv,
                Israel
            A
                Member of Ernst & Young GlobalApril
                2, 2008
## In the Court of Appeals Second Appellate District of Texas at Fort Worth

___________________________

No. 02

- 20

- 00269

- CV

___________________________

On Appeal from the 96th Distri ct Court 

### L OUIS 

### R AY 

### M ARTINEZ 

### , S R 

### ., I NDIVIDUALLY 

### , AND AS 

### P ERSONAL 

### R EPRESENTATIVE AND 

### / OR 

### E XECUTOR OF THE 

### E STATE OF 

### C ARMEN 

### M EZA 

### M ARTINEZ 

### , D ECEASED 

### , C YNTHIA 

### M ARTINEZ 

### R ODRIGUEZ 

### , J OE 

### B ENJAMIN 

### R ANGEL 

### , J R 

### ., M ICHAEL 

### A NTHONY 

### R ANGEL 

### , L OUIS 

### R AY 

### M ARTINEZ 

### , J R 

### ., AND 

### J ONATHAN 

### F RANK 

### M ARTINEZ 

### , Appellants

V



### .

B AYLOR 

### U NIVERSITY 

### M EDICAL 

### C ENTER 

### ; M ARK 

### E DWARD 

### B ANKER 

### , M.D.; J OHN 

### M ARK 

### B AY OUTH 

### , M.D.; L ENKA 

### S TANKOVA 

### , M.D.; G ERALD 

### R OBERT 

### S TEPHENSON 

### , J R 

### .; M.D.; R ACHEL 

### T AY 

### , M.D.; R AJESH 

### R AMESH 

### G ANDHI 

### , M.D.; J ESSICA 

### G ONZALEZ 

### , M.D.; D AVID 

### B. M C 

### R EYNOLDS 

### , M.D.; R OBERT 

### M EDELL 

### , M.D.; H AIBO 

### W ANG 

### , M.D.; A MANDA 

### B ULL 

### , CRNA; A SHLEY 

### J ONES 

### , CRNA; S TEPHEN 

### P A RRISH 

### , CRNA; AND 

### G ABRIEL 

### T ROHA 

### , CRNA , Appellees2 Tarrant County, Texas Trial Court No. 096

- 282882

- 15

Before Wallach, J.; Sudderth, C.J.; and Walker, J. Per Curiam Memorandum Opinion3 MEMORANDUM OPINION AND JUDGMENT

We have considered “Appellant s ’ Motion to Dismiss ” and “ Appellees ’ Joint

Response to Appellants ’ Motion to Dismiss. ” We grant the m otion and di smiss this

appeal as to all parties

. See Tex. R. App. P. 42.1(a)(1), 43.2(f).

Appellant s must pay all costs of this appeal. See Tex. R. App. P. 42.1(d ), 43.4.

Pe r Curiam

Delivered : January 28, 2021
Exhibit 15.1





Consent of Independent Registered Public Accounting Firm




We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-12586, 333-13786, 333-14142, 333-83914, 333-104070, 333-121229, 333-138717, 333-148316 and 333-161004) of our reports dated March22, 2010, with respect to the consolidated financial statements of Alvarion Ltd. and its subsidiaries and the effectiveness of internal control over financial reporting of Alvarion Ltd. and its subsidiaries included in this Annual Report (Form 20-F) for the year ended December 31, 2009.








KOST, FORER GABBAY  & KASIERERTel-Aviv, Israel
A Member of Ernst & Young GlobalMarch 26, 2010
Gerard /s



# Fourth Court of Appeals

**San Antonio, Texas**

July 21, 2015

N o. 04

- 14

- 00301

- CV

CITY OF SAN ANTONIO

, Appellant

v.

Gerard CORTES

, Ap pellee

From the 285th Judicial District Court, Bexar County, Texas

Trial Court No. 2014

- CI

- 05707

Honorable Laura Salinas, Judge Presiding



### ORDER

Sitting: Sandee Bryan Marion, Chief Justice

Karen Angelini, Justice

Marialyn Barnard, Justice

Rebeca C . Martinez, Justice (dissenting without opinion)

Patricia O. Alvarez, Justice

Luz Elena D. Chapa, Justice

Jason Pulliam, Justice

Appellee Gerard Cortes’s M otion for En Banc Reconsideration is DENIED.

_________________________________ Karen Angelini, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 21st day of July, 2015

.

___________________________________ K eith E. Hottle

Clerk of Court
|   | (a) | our periodic report on Form 10-K for the year ended December 31, 2012 (the “Form 10-K”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended, and related interpretations; and |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and our results of operations. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------|

| By:    | /s/ Gerald D. Schiefelbein |
|--------|----------------------------|
|   | Gerald D. Schiefelbein     |
|   | Chief Financial Officer    |
|   |                       |
| Date:  | March 18, 2013             |

----
<PAGE>   1

                                                                    EXHIBIT 23.4

                      CONSENT OF JOE C. NEAL & ASSOCIATES

As independent oil and gas consultants, Joe C. Neal & Associates hereby consents
to the use of our reserve report dated as of January 1, 2001 and all references
to our firm included in or made a part of the Ivanhoe Energy Inc. Annual Report
on Form 10-K to be filed with the Securities and Exchange Commission on or about
March 30, 2001.

                                          /s/ JOE C. NEAL & ASSOCIATES
                                          --------------------------------------
                                          Joe C. Neal & Associates

                                          March 14, 2001

                                       E-66
I 

108TH CONGRESS 

1ST SESSION H. R. 741

To amend the Internal Revenue Code of 1986 to allow the deduction for 

health insurance costs of self-employed individuals to be allowed in computing self-employment taxes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 12, 2003

Ms. LORETTA SANCHEZ of California (for herself, Mr. CROWLEY, and Mr. 

TANCREDO) introduced the following bill; which was referred to the Committee on Ways and Means 

A BILL

To amend the Internal Revenue Code of 1986 to allow the 

deduction for health insurance costs of self-employed individuals to be allowed in computing self-employment 

taxes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Self-Employed Health 

5 Equity Adjustment to Lower Tax Hindrance Act’’. 
2

•HR 741 IH 

1 SEC. 2. ALLOWANCE OF HEALTH INSURANCE DEDUCTION 

2 FOR SELF-EMPLOYED INDIVIDUALS FOR PUR3 POSES OF SELF-EMPLOYMENT TAX. 

4 (a) IN GENERAL.—Section 162(l) of the Internal 

5 Revenue Code of 1986 (relating to special rules for health 

6 insurance costs of self-employed individuals) is amended 

7 by striking paragraph (4) (relating to deduction not al8 lowed for self-employment tax purposes) and redesignating 

9 paragraph (5) as paragraph (4). 

10 (b) EFFECTIVE DATE.—The amendment made by 

11 this section shall apply to taxable years beginning after 

12 December 31, 2003.

Æ
# 20QRTL6_00
[Federal Register Volume 74, Number 140 (Thursday, July 23, 2009)]
[Notices]
[Page 36495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-17438]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, CD8 Immune Responses Against Viral 
Pathogens.
    Date: August 19, 2009.
    Time: 12 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6700B Rockledge Drive, 
Room 3128, Bethesda, MD 20817 (Telephone Conference Call).
    Contact Person: Katrin Eichelberg, PhD, Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, NIAID/NIH/DHHS, 6700B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892, 301-496-0818, <a href="/cdn-cgi/l/email-protection#7f141a161c171a131d1a0d183f11161e161b5111161751181009"><span class="__cf_email__" data-cfemail="78131d111b101d141a1d0a1f38161119111c56161110561f170e">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: July 16, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-17438 Filed 7-22-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit
32.1




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of Grace 7, Inc. (the “Registrant”) on Form
10-Q for the period ended February 28, 2009 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, Virginia K. Sourlis,
Principal Executive Officer and the Principal Financial Officer of the
Registrant, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
knowledge:




(1) the
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934, as amended; and




(2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Registrant.




Dated:  March
18, 2009





Grace
      7, Inc.By:
              /s/ VIRGINIA K. SOURLISVirginia
      K. SourlisPresident(Principal
      Executive Officer)(Principal
      Financial Officer)
Order entered July 2 5 , 2014

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05
- 13
- 01479
- CR
ZACHARIAH ARTHUR WIL LIAMS, Appellant V. THE STATE OF TEXAS, Appellee On Appeal from the Criminal District Court No. 3

Dallas County, Texas Tri al Court Cause No. F
- 1353277
- J



### O RDER
The Court ORDERS the trial court to conduct a hearing to determine why appellant’s brief has not been filed. In this regard, the trial court shall make appropriate findings and recommendations and determine whether a ppellant desires to prosecute the appeal, whether appellant is indigent, or if not indigent, whether retained counsel has abandoned the appeal. See
T EX
. R. A PP
. P. 38.8( b ). If the trial court cannot obtain appellant’s presence at the hearing, the trial c ourt shall conduct the hearing in appellant’s absence. See Meza v. State , 742 S.W.2d 708 (Tex. App.

– Corpus Christi 1987, no pet.) (per curiam). If appellant is indigent, the trial court is ORDERED to take such measures as may be necessary to assure effec tive representation, which may include appointment of new counsel.We ORDER the trial court to transmit a record of the proceedings, which shall include

written findings and recommendations, to this Court within THIRTY DAYS of the date of this order. Thi s appeal is ABATED to allow the trial court to comply with the above order. The appeal shall be reinstated thirty days from the date of this order or when the findings are received, whichever is earlier. /s/ DAVID EVANS JUSTICE
[Federal Register Volume 74, Number 139 (Wednesday, July 22, 2009)]
[Notices]
[Page 36169]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-17297]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary

[Docket ID: DOD-2009-OS-0107]


Privacy Act of 1974; System of Records

AGENCY: Defense Information Systems Agency, DoD.

ACTION: Notice to delete a system of records.

-----------------------------------------------------------------------

SUMMARY: The Defense Information Systems Agency is deleting a system of 
records notice in its existing inventory of records systems subject to 
the Privacy Act of 1974, (5 U.S.C. 552a), as amended.

DATES: This proposed action will be effective without further notice on 
August 21, 2009 unless comments are received which result in a contrary 
determination.

ADDRESSES: Send comments to the Defense Information Systems Agency, 
5600 Columbia Pike, Room 933-I, Falls Church, VA 22041-2705.

FOR FURTHER INFORMATION CONTACT: Ms. Jeanette M. Weathers-Jenkins at 
(703) 681-2103.

SUPPLEMENTARY INFORMATION: The Defense Information Systems Agency 
systems of records notices subject to the Privacy Act of 1974, (5 
U.S.C. 552a), as amended, have been published in the Federal Register 
and are available from the address above.
    The Defense Information Systems Agency is proposing to delete a 
system of records notice in its existing inventory of records systems 
subject to the Privacy Act of 1974, (5 U.S.C. 552a), as amended. The 
proposed deletion is not within the purview of subsection (r) of the 
Privacy Act of 1974, (5 U.S.C. 552a), as amended, which requires the 
submission of a new or altered system report.

    Dated: July 16, 2009.
Morgan E. Frazier,
Alternate OSD Federal Register Liaison Officer, Department of Defense.

    Deletion:

KEUR.02

    DISA Form 605, Personnel Data Sheet (February 22, 1993, 58 FR 
10562).
    Reason: System form is no longer in DISA publication inventory and 
therefore should not be maintained. All information previously retained 
in the DISA Form 605 is currently maintained under KEUR 010, Personnel 
File (February 22, 1993, 58 FR 10562).

[FR Doc. E9-17297 Filed 7-21-09; 8:45 am]
BILLING CODE 5001-06-P
Case 3:11-cv-04028-AET-LHG Document 2 Filed 08/03/11 Page 1 of 5 PageID: 14
Case 3:11-cv-04028-AET-LHG Document 2 Filed 08/03/11 Page 2 of 5 PageID: 15
Case 3:11-cv-04028-AET-LHG Document 2 Filed 08/03/11 Page 3 of 5 PageID: 16
Case 3:11-cv-04028-AET-LHG Document 2 Filed 08/03/11 Page 4 of 5 PageID: 17
Case 3:11-cv-04028-AET-LHG Document 2 Filed 08/03/11 Page 5 of 5 PageID: 18
Case 3:10-cr-00398-PGS Document 21 Filed 02/04/11 Page 1 of 1 PageID: 45
[912 NYS2d 369]

#### Harvey 1390 LLC et al., Appellants, v Matthew Bodenheim et al., Respondents.

Supreme Court, Appellate Term, First Department,

September 17, 2010

*78APPEARANCES OF COUNSEL

*Belkin Burden Wenig Goldman, LLP,*New York City, for appellants. *Matthew Bodenheim,*respondent pro se. *John Cassarino,*respondent pro se.

OPINION OF THE COURT

Per Curiam.

Order, dated March 9, 2010, reversed, without costs, and tenants’ motion denied. Execution of the warrant of eviction shall be stayed for 60 days after service of a copy of this order, with notice of entry.

While Civil Court may, in appropriate circumstances, relieve a tenant from a default in payment under a stipulation settling a nonpayment summary proceeding *(see 102-116 Eighth Ave. Assoc. v Oyola,*299 AD2d 296 [2002]; *Parkchester Apts. Co. v Heim, 158*Misc 2d 982 [1993]; *see also 368 Chauncey Ave. Trust v Whitaker,*28 Misc 3d 130[A], 2010 NY Slip Op 51254[U] [2010]), circumstances sufficient to warrant such discretionary relief were not shown on this record. The February 26, 2010 short-form affidavit submitted below by tenants failed to adequately explain their failure to comply with the unambiguous payment terms of the October 2009 “so-ordered” settlement stipulation or the ensuing court order. The tenants’ apparent difficulty in obtaining funds did not constitute “good cause” required to vacate the warrant of eviction (RPAPL 749 [3]; *see Chelsea 19 Assoc. v James,*67 AD3d 601 [2009]), at least on this record which contains no indication that tenants made timely efforts to comply with the monetary terms of the settlement agreement, “only to be stymied by events beyond [their] control” *(cf. 2246 Holding Corp. v Nolasco,*52 AD3d 377, 378 [2008]). We note that, so far as shown, tenants took no steps to obtain the stipulated arrearages through recourse to charitable organizations or otherwise until after the payment due date agreed upon in the stipulation.

McKeon, PJ., Shulman and Hunter, Jr., JJ., concur.